These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 34268414)
1. Collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models. Shen Z; Su T; Chen J; Xie Z; Li J Ann Transl Med; 2021 May; 9(9):801. PubMed ID: 34268414 [TBL] [Abstract][Full Text] [Related]
2. Collagen triple helix repeat containing-1 inhibits transforming growth factor-b1-induced collagen type I expression in keloid. Li J; Cao J; Li M; Yu Y; Yang Y; Xiao X; Wu Z; Wang L; Tu Y; Chen H Br J Dermatol; 2011 May; 164(5):1030-6. PubMed ID: 21667528 [TBL] [Abstract][Full Text] [Related]
3. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1. Jin J; Togo S; Kadoya K; Tulafu M; Namba Y; Iwai M; Watanabe J; Nagahama K; Okabe T; Hidayat M; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Sasaki S; Tominaga S; Takahashi K Respir Res; 2019 Jun; 20(1):119. PubMed ID: 31185973 [TBL] [Abstract][Full Text] [Related]
4. Baicalein alleviates fibrosis and inflammation in systemic sclerosis by regulating B-cell abnormalities. Peng B; Hu Q; He R; Hou H; Lian D; Chen Y; Li H; Song L; Gao Y; Chen T; Zhang G; Li J BMC Complement Med Ther; 2023 Feb; 23(1):62. PubMed ID: 36810081 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-411-3p inhibits bleomycin-induced skin fibrosis by regulating transforming growth factor-β/Smad ubiquitin regulatory factor-2 signalling. Zhang Z; Gao X; He Y; Kang Y; Jin F; Li Y; Li T; Wei Z; Li S; Cai W; Mao N; Wang S; Liu H; Yang F; Xu H; Yang J J Cell Mol Med; 2021 Dec; 25(24):11290-11299. PubMed ID: 34783198 [TBL] [Abstract][Full Text] [Related]
6. Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung function. Binks AP; Beyer M; Miller R; LeClair RJ Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28292882 [TBL] [Abstract][Full Text] [Related]
7. Arctigenin suppresses fibroblast activity and extracellular matrix deposition in hypertrophic scarring by reducing inflammation and oxidative stress. Jiang L; Deng Y; Li W; Lu Y Mol Med Rep; 2020 Dec; 22(6):4783-4791. PubMed ID: 33174021 [TBL] [Abstract][Full Text] [Related]
8. Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice. Song Y; Zhu L; Li M Clinics (Sao Paulo); 2013 Oct; 68(10):1350-7. PubMed ID: 24212843 [TBL] [Abstract][Full Text] [Related]
9. Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis. Xie X; Gan H; Tian J; Li F; Chen J; Wang J; Liao J; Li S Eur J Clin Invest; 2022 Aug; 52(8):e13791. PubMed ID: 35441708 [TBL] [Abstract][Full Text] [Related]
10. COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis. Nakai K; Karita S; Igarashi J; Tsukamoto I; Hirano K; Kubota Y J Dermatol Sci; 2019 Apr; 94(1):205-212. PubMed ID: 30954335 [TBL] [Abstract][Full Text] [Related]
11. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related]
12. Astragalus polysaccharide suppresses excessive collagen accumulation in a murine model of bleomycin-induced scleroderma. Hao ZF; Su YM; Liu JY; Wang CM; Yang RY Int J Clin Exp Med; 2015; 8(3):3848-54. PubMed ID: 26064283 [TBL] [Abstract][Full Text] [Related]
13. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis. Mou F; Mou C Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905 [TBL] [Abstract][Full Text] [Related]
14. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756 [TBL] [Abstract][Full Text] [Related]
15. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma. Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317 [TBL] [Abstract][Full Text] [Related]
16. Increased Cthrc1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location. Zhao MJ; Chen SY; Qu XY; Abdul-Fattah B; Lai T; Xie M; Wu SD; Zhou YW; Huang CZ Curr Med Sci; 2018 Oct; 38(5):894-902. PubMed ID: 30341526 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target. Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272 [TBL] [Abstract][Full Text] [Related]
19. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis. Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939 [TBL] [Abstract][Full Text] [Related]
20. Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced scleroderma. Kajii M; Suzuki C; Kashihara J; Kobayashi F; Kubo Y; Miyamoto H; Yuuki T; Yamamoto T; Nakae T Clin Exp Immunol; 2011 Feb; 163(2):235-41. PubMed ID: 21091669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]